2 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 33,00 € Taxes included to order
    Pages Iconography Videos Other
    3 2 0 0

Pratiques en nutrition
Volume 11, n° 41
pages 43-45 (janvier 2015)
Doi : 10.1016/j.pranut.2014.12.008
Microbiote intestinal, cholestérol et maladies cardiovasculaires
Gut microbiota, cholesterol and cardiovascular diseases

Philippe Gérard a, , b  : chercheur
a Institut Micalis, INRA, UMR1319, Équipe AMIPEM, Domaine de Vilvert, 78350 Jouy-en-Josas, France 
b AgroParisTech, UMR Micalis, 78350 Jouy-en-Josas, France 

Auteur correspondant.

Le tube digestif héberge un écosystème microbien complexe et spécifique à chaque individu, appelé microbiote intestinal. Plusieurs études récentes ont mis en évidence une influence de ce microbiote sur les métabolismes glucidique et lipidique de son hôte. En particulier, certaines bactéries sont capables de métaboliser le cholestérol ou de convertir les acides biliaires, et ainsi d’influencer le taux de cholestérol sanguin. Ces données suggèrent que le microbiote intestinal a la faculté de moduler le développement de l’athérosclérose et des maladies cardiovasculaires et qu’il pourrait dans l’avenir constituer une nouvelle cible thérapeutique pour prévenir ou traiter ces pathologies.

The full text of this article is available in PDF format.

The digestive tract harbours a complex microbial ecosystem specific to each individual, called gut microbiota. Several recent studies have highlighted the influence of this microbiota on the glucidic and lipid metabolisms of its host. In particular, some bacteria are capable of metabolising cholesterol or converting bile acids, and thereby influencing the level of cholesterol in the blood. These studies suggest that gut microbiota is able to modulate the development of atherosclerosis and cardiovascular diseases and that it could in the future constitute a new therapeutic target for preventing or treating these pathologies.

The full text of this article is available in PDF format.

Mots clés : athérosclérose, cholestérol, maladie cardiovasculaire, microbiote intestinal, prébiotique

Keywords : atherosclerosis, cardiovascular disease, cholesterol, gut microbiota, prebiotic

© 2014  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline